25 XP   0   0   10

ANUH PHARMA LTD.
Buy, Hold or Sell?

Let's analyse ANUH PHARMA LTD. together

PenkeI guess you are interested in ANUH PHARMA LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of ANUH PHARMA LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about ANUH PHARMA LTD.

I send you an email if I find something interesting about ANUH PHARMA LTD..

Quick analysis of ANUH PHARMA LTD. (30 sec.)










What can you expect buying and holding a share of ANUH PHARMA LTD.? (30 sec.)

How much money do you get?

How much money do you get?
INR0.08
When do you have the money?
1 year
How often do you get paid?
80.0%

What is your share worth?

Current worth
INR48.14
Expected worth in 1 year
INR70.05
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR28.89
Return On Investment
11.8%

For what price can you sell your share?

Current Price per Share
INR245.60
Expected price per share
INR186.00 - INR
How sure are you?
50%

1. Valuation of ANUH PHARMA LTD. (5 min.)




Live pricePrice per Share (EOD)

INR245.60

Intrinsic Value Per Share

INR122.80 - INR147.51

Total Value Per Share

INR170.93 - INR195.65

2. Growth of ANUH PHARMA LTD. (5 min.)




Is ANUH PHARMA LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$28.9m$25.6m$3.2m11.4%

How much money is ANUH PHARMA LTD. making?

Current yearPrevious yearGrowGrow %
Making money$4.3m$3.6m$674.1k15.5%
Net Profit Margin6.9%6.3%--

How much money comes from the company's main activities?

3. Financial Health of ANUH PHARMA LTD. (5 min.)




What can you expect buying and holding a share of ANUH PHARMA LTD.? (5 min.)

Welcome investor! ANUH PHARMA LTD.'s management wants to use your money to grow the business. In return you get a share of ANUH PHARMA LTD..

What can you expect buying and holding a share of ANUH PHARMA LTD.?

First you should know what it really means to hold a share of ANUH PHARMA LTD.. And how you can make/lose money.

Speculation

The Price per Share of ANUH PHARMA LTD. is INR245.60. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of ANUH PHARMA LTD..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in ANUH PHARMA LTD., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR48.14. Based on the TTM, the Book Value Change Per Share is INR5.48 per quarter. Based on the YOY, the Book Value Change Per Share is INR4.62 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR1.75 per quarter.
Based on historical numbers we can estimate the returns while holding a share of ANUH PHARMA LTD..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.090.0%0.090.0%0.070.0%0.060.0%0.060.0%
Usd Book Value Change Per Share0.070.0%0.070.0%0.060.0%0.120.0%0.120.0%
Usd Dividend Per Share0.020.0%0.020.0%0.020.0%0.020.0%0.020.0%
Usd Total Gains Per Share0.090.0%0.090.0%0.070.0%0.130.1%0.130.1%
Usd Price Per Share0.96-0.96-1.03-1.22-1.22-
Price to Earnings Ratio11.03-11.03-14.09-22.17-22.17-
Price-to-Total Gains Ratio11.02-11.02-14.04-17.18-17.18-
Price to Book Ratio1.65-1.65-2.01-2.75-2.75-
Price-to-Total Gains Ratio11.02-11.02-14.04-17.18-17.18-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.9472
Number of shares339
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.02
Usd Book Value Change Per Share0.070.12
Usd Total Gains Per Share0.090.13
Gains per Quarter (339 shares)29.3845.63
Gains per Year (339 shares)117.54182.53
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1288910826157173
25717822652313356
38526734478470539
4114357462103627722
5142446580129783905
61705356981559401088
719962481618110971271
822771393420712531454
9256802105223314101637
10284891117025915671820

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%4.01.00.080.0%4.01.00.080.0%
Dividend per Share1.00.00.0100.0%2.00.01.066.7%4.00.01.080.0%4.00.01.080.0%4.00.01.080.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%

Fundamentals of ANUH PHARMA LTD.

About ANUH PHARMA LTD.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of ANUH PHARMA LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit ANUH PHARMA LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare ANUH PHARMA LTD. to the  industry mean.
  • A Net Profit Margin of 6.9% means that ₹0.07 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ANUH PHARMA LTD.:

  • The MRQ is 6.9%. The company is making a profit. +1
  • The TTM is 6.9%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ6.9%TTM6.9%0.0%
TTM6.9%YOY6.3%+0.6%
TTM6.9%5Y6.3%+0.5%
5Y6.3%10Y6.3%0.0%
1.1.2. Return on Assets

Shows how efficient ANUH PHARMA LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare ANUH PHARMA LTD. to the  industry mean.
  • 8.9% Return on Assets means that ANUH PHARMA LTD. generated ₹0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ANUH PHARMA LTD.:

  • The MRQ is 8.9%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 8.9%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ8.9%TTM8.9%0.0%
TTM8.9%YOY8.8%+0.1%
TTM8.9%5Y8.1%+0.9%
5Y8.1%10Y8.1%0.0%
1.1.3. Return on Equity

Shows how efficient ANUH PHARMA LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare ANUH PHARMA LTD. to the  industry mean.
  • 15.0% Return on Equity means ANUH PHARMA LTD. generated ₹0.15 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ANUH PHARMA LTD.:

  • The MRQ is 15.0%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 15.0%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ15.0%TTM15.0%0.0%
TTM15.0%YOY14.3%+0.7%
TTM15.0%5Y13.4%+1.6%
5Y13.4%10Y13.4%0.0%

1.2. Operating Efficiency of ANUH PHARMA LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient ANUH PHARMA LTD. is operating .

  • Measures how much profit ANUH PHARMA LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare ANUH PHARMA LTD. to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ANUH PHARMA LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y3.5%-3.5%
5Y3.5%10Y3.5%0.0%
1.2.2. Operating Ratio

Measures how efficient ANUH PHARMA LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.68 means that the operating costs are ₹1.68 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of ANUH PHARMA LTD.:

  • The MRQ is 1.677. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.677. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.677TTM1.6770.000
TTM1.677YOY1.700-0.023
TTM1.6775Y1.679-0.003
5Y1.67910Y1.6790.000

1.3. Liquidity of ANUH PHARMA LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if ANUH PHARMA LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 1.91 means the company has ₹1.91 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of ANUH PHARMA LTD.:

  • The MRQ is 1.907. The company is able to pay all its short-term debts. +1
  • The TTM is 1.907. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.907TTM1.9070.000
TTM1.907YOY1.976-0.069
TTM1.9075Y1.798+0.108
5Y1.79810Y1.7980.000
1.3.2. Quick Ratio

Measures if ANUH PHARMA LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare ANUH PHARMA LTD. to the  industry mean.
  • A Quick Ratio of 1.38 means the company can pay off ₹1.38 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ANUH PHARMA LTD.:

  • The MRQ is 1.378. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.378. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.378TTM1.3780.000
TTM1.378YOY1.201+0.178
TTM1.3785Y1.128+0.250
5Y1.12810Y1.1280.000

1.4. Solvency of ANUH PHARMA LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of ANUH PHARMA LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare ANUH PHARMA LTD. to industry mean.
  • A Debt to Asset Ratio of 0.40 means that ANUH PHARMA LTD. assets are financed with 40.4% credit (debt) and the remaining percentage (100% - 40.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ANUH PHARMA LTD.:

  • The MRQ is 0.404. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.404. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.404TTM0.4040.000
TTM0.404YOY0.384+0.020
TTM0.4045Y0.407-0.002
5Y0.40710Y0.4070.000
1.4.2. Debt to Equity Ratio

Measures if ANUH PHARMA LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare ANUH PHARMA LTD. to the  industry mean.
  • A Debt to Equity ratio of 67.9% means that company has ₹0.68 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ANUH PHARMA LTD.:

  • The MRQ is 0.679. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.679. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.679TTM0.6790.000
TTM0.679YOY0.624+0.055
TTM0.6795Y0.704-0.025
5Y0.70410Y0.7040.000

2. Market Valuation of ANUH PHARMA LTD.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings ANUH PHARMA LTD. generates.

  • Above 15 is considered overpriced but always compare ANUH PHARMA LTD. to the  industry mean.
  • A PE ratio of 11.03 means the investor is paying ₹11.03 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ANUH PHARMA LTD.:

  • The EOD is 34.018. Based on the earnings, the company is overpriced. -1
  • The MRQ is 11.028. Based on the earnings, the company is underpriced. +1
  • The TTM is 11.028. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD34.018MRQ11.028+22.990
MRQ11.028TTM11.0280.000
TTM11.028YOY14.093-3.065
TTM11.0285Y22.172-11.144
5Y22.17210Y22.1720.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ANUH PHARMA LTD.:

  • The EOD is 23.509. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 7.621. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 7.621. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD23.509MRQ7.621+15.888
MRQ7.621TTM7.6210.000
TTM7.621YOY15.807-8.185
TTM7.6215Y3.616+4.005
5Y3.61610Y3.6160.000
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of ANUH PHARMA LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 1.65 means the investor is paying ₹1.65 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of ANUH PHARMA LTD.:

  • The EOD is 5.102. Based on the equity, the company is overpriced. -1
  • The MRQ is 1.654. Based on the equity, the company is underpriced. +1
  • The TTM is 1.654. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD5.102MRQ1.654+3.448
MRQ1.654TTM1.6540.000
TTM1.654YOY2.015-0.361
TTM1.6545Y2.752-1.098
5Y2.75210Y2.7520.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of ANUH PHARMA LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--5.4775.4770%4.616+19%9.627-43%9.627-43%
Book Value Per Share--48.13648.1360%42.659+13%38.811+24%38.811+24%
Current Ratio--1.9071.9070%1.976-4%1.798+6%1.798+6%
Debt To Asset Ratio--0.4040.4040%0.384+5%0.407-1%0.407-1%
Debt To Equity Ratio--0.6790.6790%0.624+9%0.704-4%0.704-4%
Dividend Per Share--1.7461.7460%1.508+16%1.590+10%1.590+10%
Eps--7.2207.2200%6.099+18%5.302+36%5.302+36%
Free Cash Flow Per Share--10.44710.4470%5.438+92%1.844+466%1.844+466%
Free Cash Flow To Equity Per Share--10.44710.4470%5.438+92%2.469+323%2.469+323%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--147.514--------
Intrinsic Value_10Y_min--122.796--------
Intrinsic Value_1Y_max--6.055--------
Intrinsic Value_1Y_min--5.884--------
Intrinsic Value_3Y_max--24.844--------
Intrinsic Value_3Y_min--23.345--------
Intrinsic Value_5Y_max--51.652--------
Intrinsic Value_5Y_min--46.882--------
Market Cap--3989917440.0003989917440.0000%4307126400.000-7%5087570688.000-22%5087570688.000-22%
Net Profit Margin--0.0690.0690%0.063+9%0.063+8%0.063+8%
Operating Margin----0%-0%0.035-100%0.035-100%
Operating Ratio--1.6771.6770%1.700-1%1.6790%1.6790%
Pb Ratio5.102+68%1.6541.6540%2.015-18%2.752-40%2.752-40%
Pe Ratio34.018+68%11.02811.0280%14.093-22%22.172-50%22.172-50%
Price Per Share245.600+68%79.62079.6200%85.950-7%101.524-22%101.524-22%
Price To Free Cash Flow Ratio23.509+68%7.6217.6210%15.807-52%3.616+111%3.616+111%
Price To Total Gains Ratio34.002+68%11.02311.0230%14.036-21%17.177-36%17.177-36%
Quick Ratio--1.3781.3780%1.201+15%1.128+22%1.128+22%
Return On Assets--0.0890.0890%0.088+1%0.081+11%0.081+11%
Return On Equity--0.1500.1500%0.143+5%0.134+12%0.134+12%
Total Gains Per Share--7.2237.2230%6.124+18%11.217-36%11.217-36%
Usd Book Value--28946568.00028946568.0000%25652736.000+13%23338749.600+24%23338749.600+24%
Usd Book Value Change Per Share--0.0660.0660%0.055+19%0.116-43%0.116-43%
Usd Book Value Per Share--0.5780.5780%0.512+13%0.466+24%0.466+24%
Usd Dividend Per Share--0.0210.0210%0.018+16%0.019+10%0.019+10%
Usd Eps--0.0870.0870%0.073+18%0.064+36%0.064+36%
Usd Free Cash Flow--6282180.0006282180.0000%3269868.000+92%1109032.800+466%1109032.800+466%
Usd Free Cash Flow Per Share--0.1250.1250%0.065+92%0.022+466%0.022+466%
Usd Free Cash Flow To Equity Per Share--0.1250.1250%0.065+92%0.030+323%0.030+323%
Usd Market Cap--47879009.28047879009.2800%51685516.800-7%61050848.256-22%61050848.256-22%
Usd Price Per Share2.947+68%0.9550.9550%1.031-7%1.218-22%1.218-22%
Usd Profit--4341552.0004341552.0000%3667356.000+18%3188361.600+36%3188361.600+36%
Usd Revenue--63298320.00063298320.0000%58397544.000+8%49769188.800+27%49769188.800+27%
Usd Total Gains Per Share--0.0870.0870%0.073+18%0.135-36%0.135-36%
 EOD+2 -4MRQTTM+0 -0YOY+27 -75Y+25 -1010Y+25 -10

3.2. Fundamental Score

Let's check the fundamental score of ANUH PHARMA LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1534.018
Price to Book Ratio (EOD)Between0-15.102
Net Profit Margin (MRQ)Greater than00.069
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.378
Current Ratio (MRQ)Greater than11.907
Debt to Asset Ratio (MRQ)Less than10.404
Debt to Equity Ratio (MRQ)Less than10.679
Return on Equity (MRQ)Greater than0.150.150
Return on Assets (MRQ)Greater than0.050.089
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of ANUH PHARMA LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.626
Ma 20Greater thanMa 50224.090
Ma 50Greater thanMa 100201.365
Ma 100Greater thanMa 200177.456
OpenGreater thanClose252.450
Total5/5 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets4,049,802
Total Liabilities1,637,588
Total Stockholder Equity2,412,214
 As reported
Total Liabilities 1,637,588
Total Stockholder Equity+ 2,412,214
Total Assets = 4,049,802

Assets

Total Assets4,049,802
Total Current Assets3,076,119
Long-term Assets973,683
Total Current Assets
Cash And Cash Equivalents 19,268
Short-term Investments 511,502
Net Receivables 1,712,276
Inventory 726,363
Total Current Assets  (as reported)3,076,119
Total Current Assets  (calculated)2,969,409
+/- 106,710
Long-term Assets
Property Plant Equipment 526,751
Intangible Assets 1,311
Long-term Assets Other 7
Long-term Assets  (as reported)973,683
Long-term Assets  (calculated)528,069
+/- 445,614

Liabilities & Shareholders' Equity

Total Current Liabilities1,613,353
Long-term Liabilities24,235
Total Stockholder Equity2,412,214
Total Current Liabilities
Accounts payable 1,527,651
Other Current Liabilities 36,106
Total Current Liabilities  (as reported)1,613,353
Total Current Liabilities  (calculated)1,563,757
+/- 49,596
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt9,067
Long-term Liabilities  (as reported)24,235
Long-term Liabilities  (calculated)9,067
+/- 15,168
Total Stockholder Equity
Retained Earnings 1,135,936
Total Stockholder Equity (as reported)2,412,214
Total Stockholder Equity (calculated)1,135,936
+/- 1,276,278
Other
Capital Stock250,560
Common Stock Shares Outstanding 50,112
Net Invested Capital 2,412,214
Net Working Capital 1,462,766
Property Plant and Equipment Gross 991,424



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
0
0
2,402,731
3,263,743
3,326,394
3,471,743
4,049,802
4,049,8023,471,7433,326,3943,263,7432,402,73100
   > Total Current Assets 
1,379,637
1,541,755
1,521,802
2,229,549
2,377,300
2,586,870
3,076,119
3,076,1192,586,8702,377,3002,229,5491,521,8021,541,7551,379,637
       Cash And Cash Equivalents 
0
0
72,724
18,452
21,984
37,958
19,268
19,26837,95821,98418,45272,72400
       Short-term Investments 
0
0
86,204
658,624
110,145
214,689
511,502
511,502214,689110,145658,62486,20400
       Net Receivables 
585,263
776,073
859,066
892,084
1,068,609
1,357,083
1,712,276
1,712,2761,357,0831,068,609892,084859,066776,073585,263
       Inventory 
298,206
319,040
428,507
614,875
814,258
799,233
726,363
726,363799,233814,258614,875428,507319,040298,206
       Other Current Assets 
46,593
48,325
73,052
42,773
-1
43,250
-1
-143,250-142,77373,05248,32546,593
   > Long-term Assets 
0
0
880,929
1,034,194
949,094
884,873
973,683
973,683884,873949,0941,034,194880,92900
       Property Plant Equipment 
172,131
222,483
546,782
837,539
711,825
613,409
526,751
526,751613,409711,825837,539546,782222,483172,131
       Intangible Assets 
0
0
3,457
2,890
2,399
1,825
1,311
1,3111,8252,3992,8903,45700
       Long-term Assets Other 
0
0
0
32
0
0
7
70032000
> Total Liabilities 
0
0
756,703
1,641,669
1,419,959
1,334,015
1,637,588
1,637,5881,334,0151,419,9591,641,669756,70300
   > Total Current Liabilities 
474,185
586,290
748,019
1,627,090
1,394,693
1,309,058
1,613,353
1,613,3531,309,0581,394,6931,627,090748,019586,290474,185
       Short Long Term Debt 
0
0
43,857
445,600
135,977
31,110
0
031,110135,977445,60043,85700
       Accounts payable 
421,830
519,838
589,159
1,046,387
1,200,159
1,215,742
1,527,651
1,527,6511,215,7421,200,1591,046,387589,159519,838421,830
       Other Current Liabilities 
43,722
37,601
109,722
123,361
9,983
1
36,106
36,10619,983123,361109,72237,60143,722
   > Long-term Liabilities 
0
0
8,684
14,579
25,266
24,957
24,235
24,23524,95725,26614,5798,68400
       Capital Lease Obligations Min Short Term Debt
0
0
0
5,946
777
11,125
9,067
9,06711,1257775,946000
> Total Stockholder Equity
0
0
1,646,028
1,622,074
1,906,435
2,137,728
2,412,214
2,412,2142,137,7281,906,4351,622,0741,646,02800
   Common Stock
125,280
125,280
125,280
125,280
0
0
0
000125,280125,280125,280125,280
   Retained Earnings Total Equity0000000
   Accumulated Other Comprehensive Income 0000000
   Capital Surplus 0000000
   Treasury Stock0000000
   Other Stockholders Equity 
997
1,515
1,378
456
0
0
0
0004561,3781,515997



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue5,274,860
Cost of Revenue-4,014,824
Gross Profit1,260,0361,260,036
 
Operating Income (+$)
Gross Profit1,260,036
Operating Expense-4,830,375
Operating Income444,485-3,570,339
 
Operating Expense (+$)
Research Development0
Selling General Administrative25,463
Selling And Marketing Expenses0
Operating Expense4,830,37525,463
 
Net Interest Income (+$)
Interest Income4,498
Interest Expense-2,184
Other Finance Cost-5,279
Net Interest Income-2,965
 
Pretax Income (+$)
Operating Income444,485
Net Interest Income-2,965
Other Non-Operating Income Expenses0
Income Before Tax (EBT)474,704444,485
EBIT - interestExpense = -2,184
361,796
363,980
Interest Expense2,184
Earnings Before Interest and Taxes (EBIT)0476,888
Earnings Before Interest and Taxes (EBITDA)573,890
 
After tax Income (+$)
Income Before Tax474,704
Tax Provision-112,908
Net Income From Continuing Ops361,796361,796
Net Income361,796
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net02,965
 

Technical Analysis of ANUH PHARMA LTD.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of ANUH PHARMA LTD.. The general trend of ANUH PHARMA LTD. is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine ANUH PHARMA LTD.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ANUH PHARMA LTD..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: .

The bearish price targets are: 238.80 > 198.60 > 186.00.

Tweet this
ANUH PHARMA LTD. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ANUH PHARMA LTD.. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ANUH PHARMA LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ANUH PHARMA LTD.. The current macd is 11.63.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the ANUH PHARMA LTD. price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for ANUH PHARMA LTD.. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the ANUH PHARMA LTD. price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
ANUH PHARMA LTD. Daily Moving Average Convergence/Divergence (MACD) ChartANUH PHARMA LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ANUH PHARMA LTD.. The current adx is 30.04.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy ANUH PHARMA LTD. shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
ANUH PHARMA LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ANUH PHARMA LTD.. The current sar is 211.25.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
ANUH PHARMA LTD. Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ANUH PHARMA LTD.. The current rsi is 61.63. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
ANUH PHARMA LTD. Daily Relative Strength Index (RSI) ChartANUH PHARMA LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ANUH PHARMA LTD.. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the ANUH PHARMA LTD. price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
ANUH PHARMA LTD. Daily Stochastic Oscillator ChartANUH PHARMA LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ANUH PHARMA LTD.. The current cci is 137.18.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
ANUH PHARMA LTD. Daily Commodity Channel Index (CCI) ChartANUH PHARMA LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ANUH PHARMA LTD.. The current cmo is 24.19.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
ANUH PHARMA LTD. Daily Chande Momentum Oscillator (CMO) ChartANUH PHARMA LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ANUH PHARMA LTD.. The current willr is -23.5.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that ANUH PHARMA LTD. is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
ANUH PHARMA LTD. Daily Williams %R ChartANUH PHARMA LTD. Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ANUH PHARMA LTD..

ANUH PHARMA LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ANUH PHARMA LTD.. The current atr is 15.87.

ANUH PHARMA LTD. Daily Average True Range (ATR) ChartANUH PHARMA LTD. Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ANUH PHARMA LTD.. The current obv is 3,999,368.

ANUH PHARMA LTD. Daily On-Balance Volume (OBV) ChartANUH PHARMA LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ANUH PHARMA LTD.. The current mfi is 69.68.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
ANUH PHARMA LTD. Daily Money Flow Index (MFI) ChartANUH PHARMA LTD. Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ANUH PHARMA LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-16ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-23STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-14MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-09MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-02BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-20MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

ANUH PHARMA LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ANUH PHARMA LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.626
Ma 20Greater thanMa 50224.090
Ma 50Greater thanMa 100201.365
Ma 100Greater thanMa 200177.456
OpenGreater thanClose252.450
Total5/5 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of ANUH PHARMA LTD. with someone you think should read this too:
  • Are you bullish or bearish on ANUH PHARMA LTD.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about ANUH PHARMA LTD.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ANUH PHARMA LTD.

I send you an email if I find something interesting about ANUH PHARMA LTD..


Comments

How you think about this?

Leave a comment

Stay informed about ANUH PHARMA LTD..

Receive notifications about ANUH PHARMA LTD. in your mailbox!